Roselle
384 E. Irving Park Rd.
Roselle, IL 60172
630.529.3400 Email Us M-F 9-5pm
Sat Closed | Sun Closed
Deerfield
1020 N. Milwaukee Ave, Suite 140
Deerfield, IL 60015
847.419.9898 Email Us M-Tu 9:30-6:30pm
Wed 10-2pm Th-F 9:30-6:30pm
Sat 10-2pm | Sun Closed

Studies and References

References

  1. http://kidney.niddk.nih.gov/kudiseases/pubs/impotence/
    Zorgniotti AW, Lefleur RS: Auto-injection of the corpus cavernosum with a vasoactive
  2. Drug combination for vasculogenic impotence. J Urol 1985; 133:39-41.
  3. Armstrong DK, Convery A, Dinsmore WW: Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic. Int J STD AIDS 1993; 4:214-216.
  4. Bennett AH, Carpenter AJ, Barada JH: An improved vasoactive drug combination for a pharmacological erection program. J Urol 1991; 146:1564-1565.
  5. Evaluation and Nonsurgical Management of Erectile Dysfunction. Wein: Campbell-Walsh Urology, 9th ed. Copyright © 2007 Saunders, An Imprint of Elsevier.
    Accessed May 6, 2009.
    http://0-www.mdconsult.com.catalog.llu.edu/das/book/body/135790760-5/838123116/1445/25.html#4-u1.0-B978-0-7216-0798-6..50024-8–bib306
  6. Goldstein I, Borges FD, Fitch WP, et al: Rescuing the failed papaverine/phentolamine erection: A proposed synergistic action of papaverine, phentolamine, and PGE1 [Abstract]. J Urol 1990; 143:403A.
  7. Israilov S, Niv E, Livne PM, Shmueli J, Engelstein D, Segenreich E, Baniel J. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. Int J Impot Res. 2002 Feb;14(1):38-43.
  8. Brant WO, Bella AJ, Lue TF. Treatment Options for Erectile Dysfunction. Endocrinol Metab Clin N Am. 36(2007):465-470.
  9. Travison, T. G., Shabsigh, R., Araujo, A. B., Kupelian, V., O’Donnell, A. B., & McKinlay, J. B. (2007). The natural progression and remission of erectile dysfunction: Results from the Massachusetts Male Aging Study. Journal of Urology, 177, 241–246.
  10. Travison, T. G., Hall, S. A., Fisher, W. A., Araujo, A. B., Rosen, R. C., McKinlay, J. B. and Sand, M. S. (2011), Correlates of PDE5i Use among Subjects with Erectile Dysfunction in Two Population-Based Surveys. The Journal of Sexual Medicine. doi: 10.1111/j.1743-6109.2011.02423.x
  11. Andersen, M. L., Guindalini, C. and Tufik, S. (2011), Genetics of Erectile Dysfunction: A Review of the Interface between Sex and Molecular Biomarkers. The Journal of Sexual Medicine. doi: 10.1111/j.1743-6109.2011.02422.x

 

The information on this website should not be used to diagnose or treat patients without the specific direction and supervision of a physician. You should consult with a physician who knows your medical history and current medical conditions before using Tri-Mix or any erectile dysfunction treatments. Your treatment should be individualized for you by a prescribing physician. Tri-Mix is for the treatment of Erectile Dysfunction and is not approved by the FDA. Tri-Mix requires a prescription and can only be filled at a compounding pharmacy.
Copyright 2011

Mark Drugs Pharmacy